TGFB3 and colorectal cancer: In conclusion, this study demonstrates that MVD quantified using a Mab to CD105 is an independent prognostic parameter for survival of patients with colorectal cancer, and that plasma levels of CD105, TGFβ1, TGFβ3 and CD105/TGFβ complexes may be useful markers for assessing disease progression.